190 filings
Page 5 of 10
8-K
m3z55950967olcbx
27 Feb 15
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
dp64a3azy4ucx qi0sj
24 Dec 14
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
admu1 agaj2bl
30 Jul 14
Oxygen Biotherapeutics Announces Fiscal Year 2014 Financial Results
12:00am
8-K
5b0l6 70us8154flrg1
4 Apr 14
Oxygen Biotherapeutics Inc., Announces the Appointment of
12:00am
8-K
npmsbkvvb 0h
21 Mar 14
Oxygen Biotherapeutics Announces Proposed Public Offering
12:00am
8-K
nsip2en43ydjn9rwv
6 Mar 14
Oxygen Biotherapeutics Inc. Provides an Update on Communication
12:00am
8-K/A
k6upnpmj10 tendl3y3p
22 Jan 14
Financial Statements and Exhibits
12:00am
8-K
wornnm9wfs1ew
23 Dec 13
Departure of Directors or Certain Officers
12:00am
8-K/A
hh399cuyt97r0lxj
20 Dec 13
Submission of Matters to a Vote of Security Holders
12:00am
8-K
5mkz ohpv0p3kfh
9 Dec 13
Submission of Matters to a Vote of Security Holders
12:00am
8-K
3lu4jj
19 Nov 13
Oxygen Biotherapeutics Closes the Acquisition of
12:00am
8-K
6399q 8yae
8 Nov 13
Oxygen Biotherapeutics Receives $6 Million in Net Proceeds from Warrant Exercises
12:00am
8-K
otd4jm y5
25 Oct 13
Oxygen Biotherapeutics Signs Agreement to Acquire Phase 3, FDA Fast Track Product to Pursue Potential $600 Million Cardiovascular Market
12:00am
8-K
oca2yl mk
26 Aug 13
Entry into a Material Definitive Agreement
12:00am
8-K
1lbg972iwi4veko00gnq
13 Aug 13
Entry into a Material Definitive Agreement
12:00am
8-K/A
3uvbni4rwwz
31 Jul 13
Other Events
12:00am
8-K
xecrkx
25 Jul 13
Oxygen Biotherapeutics Prices Public Offering
12:00am
8-K
9f5u6a qx3dy
27 Jun 13
Oxygen Biotherapeutics Reports Financial Results for Fiscal Year 2013
12:00am
8-K
6ro1z
16 May 13
Oxygen Biotherapeutics Receives Favorable NASDAQ Listing Decision
12:00am
8-K
bt2 97nvl
15 May 13
Amendments to Articles of Incorporation or Bylaws
12:00am